This third volume in the series Methods of Cancer Diagnosis, Therapy and Prognosis discusses diagnosis, therapy, and prognosis of Gastrointestinal Cancers. Both standard and emerging therapies for these cancers, written by expert oncologists/pathologists in this field, are included. This fully illustrated volume * Includes various aspects of esophageal cancer, gastric cancer, and pancreatic cancer * Highlights the methodologies used for diagnosis, therapy, and prognosis of these different cancers * Explains the molecular mechanisms underlying these cancers * Discusses the evaluation of FDG-PET/CT fusion imaging, endoscopic ultrasound and imaging, and the role of microRNA in prognosis * Details the classification of colon and gastric histological samples * Highlights treatments, including radiofrequency ablation and surgical debulking, endoscopic submucosal dissection, laparoscopic gastrectomy of gastric cancer and pancreaticoduodenectomy * Reviews use of radiotherapy and chemotherapy for pancreatic cancer patients * Discusses a large number of imaging modalities for diagnosing these cancers and assessing the different treatments Professor Hayat has summarized the problems associated with the complexities of research publications and has been successful in editing a must-read volume for oncologists, cancer researchers, medical teachers and students of cancer biology.
Author(s): M. A. Hayat
Series: Methods of Cancer Diagnosis, Therapy and Prognosis volume 3
Edition: 1
Publisher: Springer
Year: 2009
Language: English
Pages: 259
Cover......Page 1
front-matter......Page 2
1. Introduction- Gastrointestinal Cancer.pdf......Page 31
2. Metastatic Gastrointestinal Cancer- Safety of Cisplatin Combined with Continuous 5-FU Versus Bolus 5-FU and Leucovorin (Methodology).pdf......Page 41
3. Gastrointestinal Cancer- Endoscopic Submucosal Dissection (Methodology).pdf......Page 50
4. Gastrointestinal Epithelial Neoplasms- Endoscopic Submucosal Dissection (Methodology).pdf......Page 56
5. Inoperable Abdomino-Pelvic Tumors- Treatment with Radio-Frequency Ablation and Surgical Debulking.pdf......Page 64
6. Gastrointestinal Neuroendocrine Tumors- Diagnosis Using Gastrin Receptor Scintigraphy.pdf......Page 69
7. Distal Esophagus- Evaluation with 18F-FDG PET-CT Fusion Imaging.pdf......Page 79
8. Endoscopic Ultrasound and Staging of Esophageal Cancer.pdf......Page 86
9. Esophageal Cancer- Role of RNASEN Protein and microRNA in Prognosis.pdf......Page 99
10. Esophageal Cancer- Initial Staging.pdf......Page 104
11. Automated Disease Classification of Colon and Gastric Histological Samples Based on Digital Microscopy and Advanced Image Analysis.pdf......Page 117
12. Early Gastric Cancer- Prediction of Metachronous Recurrence Using Endoscopic Submucosal Dissection (Methodology).pdf......Page 130
13. Helicobacter pylori -Infected Neoplastic Gastric Epithelium- Expression of MUC2 as a Biomarker.pdf......Page 138
14. Gastric Cancer- Role of Intestinal Metaplasia by Histochemical Detection Using Biopsy Specimens.pdf......Page 154
15. Gastric Cancer- Antitumor Activity of RUNX3.pdf......Page 169
16. Early Gastric Cancer- Laparoscopic Gastrectomy (Methodology).pdf......Page 179
17. Gastric Cancer- Overexpression of Hypoxia-Inducible Factor 1 as a Prognostic Factor.pdf......Page 187
18. Pancreatic Cancer- Hepatoma-Derived Growth Factor as a Prognostic Factor.pdf......Page 197
19. Pancreatic Cancer- 18F-Fluorodeoxyglucose Positron Emission Tomography as a Prognostic Parameter.pdf......Page 204
20. Imaging and Pathologic Findings of Peculiar Histologic Variants of Pancreatic Endocrine Tumors.pdf......Page 217
21. Periampullary Adenocarcinoma- Diagnosis and Survival After Pancreaticoduodenectomy.pdf......Page 223
22. Unresectable Locally Advanced Pancreatic Cancer- Concurrent Chemotherapy.pdf......Page 239
back-matter......Page 249
